Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Construction in Progress (2020 - 2026)

Updated

Analysis

Dyne Therapeutics (DYN) Construction in Progress (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.79 Mn
Dec 31, 2025 19.31 Mn
Sep 30, 2025 18.79 Mn
Mar 31, 2025 258,000.00
Dec 31, 2024 619,000.00
Sep 30, 2024 450,000.00
Jun 30, 2024 1.02 Mn
Mar 31, 2024 535,000.00
Dec 31, 2023 431,000.00
Sep 30, 2023 490,000.00
Jun 30, 2023 474,000.00
Mar 31, 2023 720,000.00
Dec 31, 2022 906,000.00
Sep 30, 2022 944,000.00
Jun 30, 2022 1.05 Mn
Mar 31, 2022 1.69 Mn
Dec 31, 2021 1.46 Mn
Dec 31, 2020 105,000.00
API Access

Dyne Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=DYN&period=max&api_key=YOUR_API_KEY